FSANZ Research grants are intended to provide financial assistance to early career researchers working in the field of reproductive medicine, reproductive biology and reproductive epidemiology.
Early career researchers are those pursuing a Masters by research or a PhD, or those who are <5 years (on the application submission deadline) after the PhD was awarded to them.
Researchers that do not hold other significant research funding (e.g. Cat 1 funding) for their research activities will be preferred.
Applicants should be citizen(s) or permanent residents of Australia or New Zealand, currently working within or in collaboration with medical, academic or research organisations of Australia and New Zealand.
Whilst research projects will not be required to conclude within a specific timeframe, grant recipients will be required to submit an abstract to the FSA conference the following year, presenting on their findings or progress to date. Organon will be noted as the grant donor during this presentation.
However, in the event the Research will not be completed by 31 December 2023, the Recipient must request an extension which is to be agreed to by Organon prior to 31 December 2023 and the Recipient acknowledged and agrees that the Funding Amount is conditional on completed research.
Applicants need to abide by the rules and policies of these research grants, including annual reporting to the FSANZ of the research progress, the allocation of funds, as well as acknowledgement of the FSANZ and Merck in any presentation or publication that is produced as a result of this research (i.e. “Organon FSANZ Research Grant”).
Research funds are awarded for discreet projects; research funds cannot be used to generate income for recipients or their organisations, nor for ‘everyday’ running of clinics and/or departments
The Head of the Department where the research will be performed needs to formally endorse (sign) the application.
A fully completed application with all necessary supporting documentation needs to have been submitted by the deadline.
The applications should be in the format indicated and of sufficient detail to allow critical appraisal by a panel of experts. The grants will be judged on:
- Innovation/ Significance of research question
- Quality of research design
- Feasibility/ Prospect of completion within the proposed time-frame
- Alignment with the nominated research priorities
- Track record of researchers and supervisory success
Only one submission per applicant will be accepted. Multi-year projects are allowed if properly justified but the funds will be paid each year conditional on the progress achieved during the previous year.
Applications for 2022 funding round can be submitted between 1 June and 31 July in 2022.
Each application will be assessed by a panel of experts (nominated by the FSANZ Board), with the help of external reviewers if required.
Recommendations on which grants should be funded and the level of funding will be made by the panel to the FSANZ Board.
Notification of successful applicant for 2022 will be made by 30 September 2022 and the funds will be provided by 31 December 2022. Notification of successful applicants will be made during the 2022 FSANZ Annual General Meeting in November and again at the FSANZ 2023 Conference.
Grant recipients need to submit a progress report (including progress of research and allocation of the funds) by 30 November of each year to the FSANZ Board.
A copy of the above information can be downloaded HERE
